-
Something wrong with this record ?
An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye
MT. Nguyen, S. Vemaraju, G. Nayak, Y. Odaka, ED. Buhr, N. Alonzo, U. Tran, M. Batie, BA. Upton, M. Darvas, Z. Kozmik, S. Rao, RS. Hegde, PM. Iuvone, RN. Van Gelder, RA. Lang,
Language English Country England, Great Britain
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R01 EY004864
NEI NIH HHS - United States
R01 EY026921
NEI NIH HHS - United States
R01 EY022917
NEI NIH HHS - United States
T32 GM063483
NIGMS NIH HHS - United States
R01 EY027077
NEI NIH HHS - United States
R01 GM124246
NIGMS NIH HHS - United States
P30 EY001730
NEI NIH HHS - United States
R01 EY027711
NEI NIH HHS - United States
R01 EY014648
NEI NIH HHS - United States
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Endothelium, Vascular metabolism MeSH
- Dopamine metabolism MeSH
- Membrane Proteins genetics metabolism MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Eye blood supply enzymology growth & development metabolism MeSH
- Opsins genetics metabolism MeSH
- Dopamine Plasma Membrane Transport Proteins antagonists & inhibitors chemistry metabolism MeSH
- Retinal Ganglion Cells metabolism radiation effects MeSH
- Vitreous Body metabolism MeSH
- Light * MeSH
- Threonine metabolism MeSH
- Vesicular Inhibitory Amino Acid Transport Proteins physiology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
During mouse postnatal eye development, the embryonic hyaloid vascular network regresses from the vitreous as an adaption for high-acuity vision. This process occurs with precisely controlled timing. Here, we show that opsin 5 (OPN5; also known as neuropsin)-dependent retinal light responses regulate vascular development in the postnatal eye. In Opn5-null mice, hyaloid vessels regress precociously. We demonstrate that 380-nm light stimulation via OPN5 and VGAT (the vesicular GABA/glycine transporter) in retinal ganglion cells enhances the activity of inner retinal DAT (also known as SLC6A3; a dopamine reuptake transporter) and thus suppresses vitreal dopamine. In turn, dopamine acts directly on hyaloid vascular endothelial cells to suppress the activity of vascular endothelial growth factor receptor 2 (VEGFR2) and promote hyaloid vessel regression. With OPN5 loss of function, the vitreous dopamine level is elevated and results in premature hyaloid regression. These investigations identify violet light as a developmental timing cue that, via an OPN5-dopamine pathway, regulates optic axis clearance in preparation for visual function.
Clinical Engineering Cincinnati Children's Hospital Medical Center Cincinnati OH USA
Department of Ophthalmology University of Washington Medical School Seattle WA USA
Division of Developmental Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA
Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic
Ophthalmic Research Cole Eye Institute Cleveland Clinic Cleveland OH USA
Pathology University of Washington Medical School Seattle WA USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027680
- 003
- CZ-PrNML
- 005
- 20190823105842.0
- 007
- ta
- 008
- 190813s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41556-019-0301-x $2 doi
- 035 __
- $a (PubMed)30936473
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nguyen, Minh-Thanh T $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 245 13
- $a An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye / $c MT. Nguyen, S. Vemaraju, G. Nayak, Y. Odaka, ED. Buhr, N. Alonzo, U. Tran, M. Batie, BA. Upton, M. Darvas, Z. Kozmik, S. Rao, RS. Hegde, PM. Iuvone, RN. Van Gelder, RA. Lang,
- 520 9_
- $a During mouse postnatal eye development, the embryonic hyaloid vascular network regresses from the vitreous as an adaption for high-acuity vision. This process occurs with precisely controlled timing. Here, we show that opsin 5 (OPN5; also known as neuropsin)-dependent retinal light responses regulate vascular development in the postnatal eye. In Opn5-null mice, hyaloid vessels regress precociously. We demonstrate that 380-nm light stimulation via OPN5 and VGAT (the vesicular GABA/glycine transporter) in retinal ganglion cells enhances the activity of inner retinal DAT (also known as SLC6A3; a dopamine reuptake transporter) and thus suppresses vitreal dopamine. In turn, dopamine acts directly on hyaloid vascular endothelial cells to suppress the activity of vascular endothelial growth factor receptor 2 (VEGFR2) and promote hyaloid vessel regression. With OPN5 loss of function, the vitreous dopamine level is elevated and results in premature hyaloid regression. These investigations identify violet light as a developmental timing cue that, via an OPN5-dopamine pathway, regulates optic axis clearance in preparation for visual function.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a dopamin $x metabolismus $7 D004298
- 650 _2
- $a proteiny přenášející dopamin přes plazmatickou membránu $x antagonisté a inhibitory $x chemie $x metabolismus $7 D050483
- 650 _2
- $a cévní endotel $x metabolismus $7 D004730
- 650 _2
- $a oči $x krevní zásobení $x enzymologie $x růst a vývoj $x metabolismus $7 D005123
- 650 12
- $a světlo $7 D008027
- 650 _2
- $a membránové proteiny $x genetika $x metabolismus $7 D008565
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a opsiny $x genetika $x metabolismus $7 D055355
- 650 _2
- $a retinální gangliové buňky $x metabolismus $x účinky záření $7 D012165
- 650 _2
- $a threonin $x metabolismus $7 D013912
- 650 _2
- $a transportéry VIAAT $x fyziologie $7 D050495
- 650 _2
- $a sklivec $x metabolismus $7 D014822
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vemaraju, Shruti $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Nayak, Gowri $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Odaka, Yoshinobu $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Buhr, Ethan D $u Department of Ophthalmology, University of Washington Medical School, Seattle, WA, USA.
- 700 1_
- $a Alonzo, Nuria $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Tran, Uyen $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Batie, Matthew $u Clinical Engineering, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Upton, Brian A $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Darvas, Martin $u Pathology, University of Washington Medical School, Seattle, WA, USA.
- 700 1_
- $a Kozmik, Zbynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Rao, Sujata $u Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
- 700 1_
- $a Hegde, Rashmi S $u Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- 700 1_
- $a Iuvone, P Michael $u Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA. Pharmacology, Emory University School of Medicine, Atlanta, GA, USA.
- 700 1_
- $a Van Gelder, Russell N $u Department of Ophthalmology, University of Washington Medical School, Seattle, WA, USA. Pathology, University of Washington Medical School, Seattle, WA, USA. Biological Structure, University of Washington Medical School, Seattle, WA, USA.
- 700 1_
- $a Lang, Richard A $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Department of Ophthalmology, University of Cincinnati, College of Medicine, Cincinnati, OH, USA. Richard.Lang@cchmc.org.
- 773 0_
- $w MED00005249 $t Nature cell biology $x 1476-4679 $g Roč. 21, č. 4 (2019), s. 420-429
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30936473 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823110057 $b ABA008
- 999 __
- $a ok $b bmc $g 1432829 $s 1066140
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 21 $c 4 $d 420-429 $e 20190401 $i 1476-4679 $m Nature cell biology $n Nat Cell Biol $x MED00005249
- GRA __
- $a R01 EY004864 $p NEI NIH HHS $2 United States
- GRA __
- $a R01 EY026921 $p NEI NIH HHS $2 United States
- GRA __
- $a R01 EY022917 $p NEI NIH HHS $2 United States
- GRA __
- $a T32 GM063483 $p NIGMS NIH HHS $2 United States
- GRA __
- $a R01 EY027077 $p NEI NIH HHS $2 United States
- GRA __
- $a R01 GM124246 $p NIGMS NIH HHS $2 United States
- GRA __
- $a P30 EY001730 $p NEI NIH HHS $2 United States
- GRA __
- $a R01 EY027711 $p NEI NIH HHS $2 United States
- GRA __
- $a R01 EY014648 $p NEI NIH HHS $2 United States
- LZP __
- $a Pubmed-20190813